Pluri Inc. (PLUR) vs Senti Biosciences, Inc. (SNTI)
A side-by-side comparison of Pluri Inc. and Senti Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PLUR
Pluri Inc.
$0.98HealthcareDelayed quote: Oct 6, 2026, 1:51 PM EDT
SNTI
Senti Biosciences, Inc.
$0.34HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — PLUR vs SNTI
growth of $100 · dividends reinvested · last 5yPLUR -96.6% (-49.1%/yr)SNTI -99.7% (-67.8%/yr)PLUR compounded faster over this window
Log scale — wide-divergence pair
PLUR SNTI
PLUR vs SNTI: by the numbers
- •PLUR is the larger company ($11M vs $10M market cap).
- •Both run net losses; PLUR's is the smaller (-2406.00% vs -90116.36% net margin).
Metrics side by side
Valuation
| Metric | PLUR | SNTI |
|---|---|---|
| P/S ratio | 10.43 | 189.93 |
Profitability
| Metric | PLUR | SNTI |
|---|---|---|
| Gross margin | 44.59% | -16431.82% |
| Operating margin | -2455.91% | -289668.18% |
| Net margin | -2406.00% | -90116.36% |
| ROIC | -127.37% | -227.67% |
Growth (annualized)
| Metric | PLUR | SNTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -43.85% |
| Total return CAGR (5Y) | -44.78% | -67.75% |
Frequently asked
- How have PLUR and SNTI total returns compared?
- Over the past 5 years, PLUR delivered -44.78% and SNTI delivered -67.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.